1. Home
  2. DAIO vs CELU Comparison

DAIO vs CELU Comparison

Compare DAIO & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Data I/O Corporation

DAIO

Data I/O Corporation

SELL

Current Price

$2.62

Market Cap

26.2M

Sector

Industrials

ML Signal

SELL

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$0.44

Market Cap

26.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAIO
CELU
Founded
1969
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.2M
26.5M
IPO Year
2026
2019

Fundamental Metrics

Financial Performance
Metric
DAIO
CELU
Price
$2.62
$0.44
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
28.4K
★ 182.4K
Earning Date
11-12-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.04
Revenue
$21,500,000.00
★ $26,550,000.00
Revenue This Year
$3.26
$165.42
Revenue Next Year
$25.00
$305.36
P/E Ratio
★ N/A
$11.70
Revenue Growth
★ N/A
N/A
52 Week Low
$2.16
$0.46
52 Week High
$4.49
$2.55

Technical Indicators

Market Signals
Indicator
DAIO
CELU
Relative Strength Index (RSI) 49.79 25.58
Support Level $2.28 N/A
Resistance Level $2.73 $0.83
Average True Range (ATR) 0.17 0.10
MACD 0.03 -0.01
Stochastic Oscillator 58.33 6.38

Price Performance

Historical Comparison
DAIO
CELU

About DAIO Data I/O Corporation

Data I/O Corp provides semiconductor programming, security provisioning, and intellectual property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices and secure microcontrollers. It operates as a single segment entity, with the sole objective to design, manufacture, and sell programming solutions and Programming-as-a-Service (PaaS) to the world's various electronics manufacturers including OEMs, CMs and EMS companies. The company operate in three separate locations Redmond, Washington; Shanghai, China; and Munich, Germany.

About CELU Celularity Inc.

Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.

Share on Social Networks: